EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yasir Abu-Omar
Shafi Mussa
Madhava J. Naik
David P. Taggart
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abu-Omar, Y.
Right arrow Articles by Taggart, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abu-Omar, Y.
Right arrow Articles by Taggart, D. P.
Related Collections
Right arrow Coronary disease
Right arrow Extracorporeal circulation

Eur J Cardiothorac Surg 2005;27:893-898
© 2005 Elsevier Science NL


Evaluation of Cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery

Yasir Abu-Omara, Shafi Mussaa, Madhava J. Naika, Noel MacCarthyb, Sue Standingc, David P. Taggarta,*

a Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford OX3 9DU, UK
b Department for Statistics in Medicine, University of Oxford, Oxford, UK
c Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford OX3 9DU, UK

Received 17 August 2004; received in revised form 7 December 2004; accepted 29 December 2004.

* Corresponding author. Tel.: +44 1865 221121; fax: +44 1865 220244. (E-mail: david.taggart{at}orh.nhs.uk).

Objective: Cardiopulmonary bypass is regarded as an important contributor to renal injury, whereas off-pump surgery is considered less damaging. Cystatin C, a cystine protease inhibitor, is more sensitive and specific than creatinine in the assessment of renal function. We assessed the value of Cystatin C in quantifying clinical and subclinical renal injury following on-pump and off-pump cardiac surgery. Methods: Sixty consecutive patients were recruited: 30 patients undergoing on-pump CABG and 30 patients undergoing off-pump CABG. Blood samples were collected pre-operatively and on days 1, 2 and 4 postoperatively to measure serum creatinine and serum Cystatin C. Urinary samples were collected concurrently to measure microalbumin and N-acetyl-ß-glucosaminidase, denoting changes in renal glomerular and tubular function respectively. Results: The off-pump group were older (65±11 vs. 61±8 years; P=0.046), had a higher mean Parsonnet score (9.4±6.2 vs. 5.4±3.6, P<0.01) and received fewer grafts (2.4±0.9 vs. 3.1±0.7; P<0.01) compared to the on-pump group. The groups were otherwise matched with respect to preoperative renal function and left ventricular function. Patients undergoing on-pump CABG had greater increases in all four parameters of renal injury. Adjustment for preoperative differences increased the size and significance of the effect of off-pump vs. on-pump surgery (percent difference 13%; 95% CI 2–26 for creatinine, and 16%; 95% CI 4–29 for Cystatin C). Cystatin and creatinine were strongly correlated with each other. Conclusions: Avoidance of cardiopulmonary bypass may reduce renal injury particularly in higher risk patients. Cystatin C proved to be a simple and sensitive measure of overall renal function and can be used in the routine assessment of renoprotective strategies.

Key Words: Renal injury • Cardiopulmonary bypass • Coronary artery bypass grafting • Off-pump




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Haase, A. Haase-Fielitz, S. Ratnaike, M. C. Reade, S. M. Bagshaw, S. Morgera, D. Dragun, and R. Bellomo
N-Acetylcysteine does not artifactually lower plasma creatinine concentration
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. G Raja and G. D Dreyfus
Current Status of Off-pump Coronary Artery Bypass Surgery
Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 164 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Zhu, R. Yin, H. Shao, G. Dong, L. Luo, and H. Jing
N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
Y. Abu-Omar and C. Ratnatunga
Cardiopulmonary Bypass and Renal Injury
Perfusion, July 1, 2006; 21(4): 209 - 213.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F.-X. Schmid, N. Vudattu, B. Floerchinger, M. Hilker, G. Eissner, M. Hoenicka, E. Holler, and D. E. Birnbaum
Endothelial apoptosis and circulating endothelial cells after bypass grafting with and without cardiopulmonary bypass.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 496 - 500.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.